PEDIATRICS Vol. 106 No. 2 August 2000, pp. 344-345
AMERICAN ACADEMY OF PEDIATRICS:
Use of Inhaled Nitric Oxide
Approval of inhaled nitric oxide by the US Food and Drug Administration for hypoxic respiratory failure of the term and near-term newborn provides an important new therapy for this serious condition. This statement addresses the conditions under which inhaled nitric oxide should be administered to the neonate with hypoxic respiratory failure.
.
This article has been cited by other articles:
![]() |
T. D. Pawlik, N. F. M. Porta, R. H. Steinhorn, E. Ogata, and R.-A. O. deRegnier Medical and Financial Impact of a Neonatal Extracorporeal Membrane Oxygenation Referral Center in the Nitric Oxide Era Pediatrics, January 1, 2009; 123(1): e17 - e24. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Khambekar, S Nichani, D K Luyt, G Peek, R K Firmin, D J Field, and H C Pandya Developmental outcome in newborn infants treated for acute respiratory failure with extracorporeal membrane oxygenation: present experience Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2006; 91(1): F21 - F25. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Van Meurs, L. L. Wright, R. A. Ehrenkranz, J. A. Lemons, M. B. Ball, W. K. Poole, R. Perritt, R. D. Higgins, W. Oh, M. L. Hudak, et al. Inhaled Nitric Oxide for Premature Infants with Severe Respiratory Failure N. Engl. J. Med., July 7, 2005; 353(1): 13 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee on Fetus and Newborn Levels of Neonatal Care Pediatrics, November 1, 2004; 114(5): 1341 - 1347. [Abstract] [Full Text] [PDF] |
||||







